Match tier Listed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Alina Viteri

Role not yet determined Is this you? Add your title

Also affiliated: St. John's Hospital (2022–2023)

3 h-index 5 pubs 27 cited

Biography and Research Information

OverviewAI-generated summary

Alina Viteri's research focuses on the clinical outcomes and management of infectious diseases, with a particular emphasis on antimicrobial resistance and the efficacy of new therapeutic agents. She has investigated the outcomes of infectious diseases consultations for specific bacterial infections, such as methicillin-susceptible *Staphylococcus aureus* bacteremia, and has examined the clinical utility of vancomycin area-under-the-curve monitoring. Her recent work also addresses emerging challenges in treating invasive fungal infections, exploring the use of newer antifungal medications like rezafungin and the broader implications of antimicrobial resistance. Viteri collaborates with researchers at the University of Arkansas for Medical Sciences, including Jacob M. Keck, Robert W. Bradsher, Juan Carlos Rico, and Ryan K. Dare. Her scholarship metrics include an h-index of 3, with five total publications and 27 citations.

Metrics

  • h-index: 3
  • Publications: 5
  • Citations: 27

Selected Publications

  • “Dusting Off the Cobwebs”: Rethinking How We Use New Antibiotics (2025)
    Antibiotics 3 citations DOI OpenAlex
  • It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis (2025)
    Infectious Diseases and Therapy 10 citations DOI OpenAlex
  • New Agents Are Coming, and So Is the Resistance (2024)
    Antibiotics 13 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

12 Collaborators 2 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics